Overview
Logica Mirror femoral stem is a CE marked medical device, and within this clinical trial it is used according to its intended use. This is a Post Marketing Clinical Follow Up trial, with the main aim to collect additional evidences on the outcome data on this product, by analysing clinical scoring systems, radiographs and adverse event records within three years after the surgery, and thus to assess the short-term performance and safety of this implant.
Eligibility
All patients that underwent partial or total hip arthroplasty and implanted with LOGICA
MIRROR femoral stem between Jan 2010 and Dec 2021 at Nemocnice Kyjov Hospital (CZ) in
accordance with the indication for use of the product and site standard of practice.
Additional Inclusion criteria:
- Availability of patients' immediate post-operative radiograph (baseline) and of a
number of follow-up x-rays that the Principal Investigator deems sufficient for an
effective radiographic implant evaluation and stability assessment;
- Patient is willing and able to complete additional follow-up evaluations if needed
after signing ICF.
Exclusion criteria
- Age < 18 years;
- Female patients who are pregnant, nursing, or planning a pregnancy